Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nipocalimab in Breast Milk of Healthy Lactating Women
NCT07669077Phase 1Recruiting
- Sponsor
- Janssen Pharmaceutical
- Start
- Jun 2026
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of nipocalimab, sponsored by Janssen Pharmaceutical. Primary endpoints: Concentration of Nipocalimab in Breast Milk and Area Under the Curve for Breast Milk Concentration. Started Jun 2026; status: recruiting.
02
Drugs
nipocalimab
Beyond the preview
Go deeper on NCT07669077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07669077.